Two types of chromosome 1p losses with opposite significance in gliomas
暂无分享,去创建一个
Olivier Delattre | Caroline Brennetot | Alain Aurias | K. Hoang-Xuan | Y. Marie | M. Sanson | O. Delattre | A. Idbaih | A. Aurias | K. Mokhtari | J. Delattre | G. Pierron | Caroline Brennetot | Gaëlle Pierron | Ahmed Idbaih | Karima Mokhtari | Marc Sanson | Yannick Marie | J. Lejeune | M. Kujas | Michèle Kujas | Julie Lejeune | Jean‐Yves Delattre | Khê Hoang‐Xuan
[1] G. Reifenberger,et al. The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.
[2] H. Ng,et al. Identification of two contiguous minimally deleted regions on chromosome 1p36.31–p36.32 in oligodendroglial tumours , 2004, British Journal of Cancer.
[3] Marc Ladanyi,et al. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[5] D K Pearl,et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.
[6] P. Kleihues,et al. Epidemiology and etiology of gliomas , 2005, Acta Neuropathologica.
[7] K. Hoang-Xuan,et al. Chromosome 1p loss: A favorable prognostic factor in low‐grade gliomas , 2005, Annals of neurology.
[8] J. Inazawa,et al. Correlation between genetic alteration and long‐term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p , 2003, Cancer.
[9] B. Scheithauer,et al. Oligodendrogliomas: Reproducibility and Prognostic Value of Histologic Diagnosis and Grading , 2001, Journal of neuropathology and experimental neurology.
[10] K. Hess,et al. Adult glioma incidence trends in the United States, 1977–2000 , 2004, Cancer.
[11] A. von Deimling,et al. Molecular Genetic Analysis of Oligodendroglial Tumors , 2005, Journal of neuropathology and experimental neurology.
[12] E G Stopa,et al. Observer reliability in histological grading of astrocytoma stereotactic biopsies. , 1996, Journal of neurosurgery.
[13] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[14] R. Fimmers,et al. Oligodendroglial Tumors: Refinement of Candidate Regions on Chromosome Arm 1p and Correlation of 1p/19q Status with Survival , 2004, Brain pathology.
[15] K. Hoang-Xuan,et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] David N Louis,et al. Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro‐Oncology , 2003, Journal of neuropathology and experimental neurology.
[17] D. Horsman,et al. Loss of Heterozygosity for Loci on Chromosome Arms 1p and 10q in Oligodendroglial Tumors: Relationship to Outcome and Chemosensitivity , 2003, Journal of Neuro-Oncology.
[18] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] F. Abdul-Karim,et al. Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading , 2000, Journal of the Neurological Sciences.